|
|
Research progress on parenteral nutrition associated cholestasis in neonates |
LYU Meng1 LIU Xiuxiang1,2 |
1.Department of Neonatology, the Affiliated Hospital of Binzhou Medical University, Shandong Province, Binzhou 256603, China;
2.Neonatal Intensive Care Unit, Qingdao Women and Children′s Hospital, Shandong Province, Qingdao 266034, China |
|
|
Abstract With the widespread use of parenteral nutrition in newborns, parenteral nutrition associated cholestasis (PNAC) has become one of the common complications in neonates, especially preterm infants. The disease often causes hepatocyte steatosis and cholestasis of the child, leads to biliary cirrhosis, which can cause liver failure and even death. Therefore, the disease should be highly valued by neonatal physicians. Due to the pathogenesis of PNAC is still unclear and controversial, this paper studys and summarizes a large number of recent literatures on PNAC, and found that PNAC is associated with premature birth and low birth weight, prolonged fasting, infection, parenteral nutrition application time, nutritional imbalance, and genetic factors. This article will review the known pathogenesis, diagnosis, treatment and new research progress.
|
|
|
|
|
[1] Lauriti G,Zani A,Aufieri R,et al. Incidence,prevention,and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children:a systematic review [J]. JPEN J Parenter Enteral Nutr,2014,38(1):70-85.
[2] Yan W,Hong L,Wang Y,et al. Retrospective Dual-Center Study of Parenteral Nutrition-Associated Cholestasis in Premature Neonates:15 Years′ Experience [J]. Nutr Clin Pract,2017,32(3):407-413.
[3] 胡艳萍,薛辛东.早产儿胃肠外营养相关性胆汁淤积研究进展[J].中国新生儿科杂志,2011,26(2):127-129.
[4] 黄国盛,廖燕,毕雷,等.极低出生体重儿肠外营养相关性胆汁淤积危险因素分析[J].中国现代医生,2011,49(15):38-40.
[5] Gutierrez IM,Kang KH,Calvert CE,et al. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure:a retrospective review [J]. J Pediatr Surg,2012,47(6):1150-1154.
[6] Kim AY,Lim RK,Han YM,et al. Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants:A Single Center Experience [J]. Pediatr Gastroenterol Hepatol Nutr,2016,19(1):61-70.
[7] 钟美娇,薛辛东.早产儿胃肠外营养相关性胆汁淤积的研究现状[J].中华妇幼临床医学杂志:电子版,2017,13(3):249-255.
[8] 刘云凤.早产极低出生体重儿胃肠外营养相关性胆汁淤积临床特征[D].杭州:浙江大学,2017.
[9] Kasmi KC,Vue PM,Anderson AL,et al. Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis [J]. Nat Commun,2018,9(1):1393.
[10] El Kasmi KC,Anderson AL,Devereaux MW,et al. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease [J]. Sci Transl Med,2013,5(206):137.
[11] Kurvinen A,Nissinen MJ,Andersson S,et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates [J]. J Pediatr Gastroenterol Nutr,2012, 54(6):803-811.
[12] Zaloga GP. Phytosterols,Lipid Administration,and Liver Disease During Parenteral Nutrition [J]. JPEN J Parenter Enteral Nutr,2015,39(1):39-60.
[13] Xu Z. The Role of Parenteral Lipids in the Development of Hepatic Dysfunction and Hepatic Steatosis in a Mouse Model of Total Parenteral Nutrition [J]. J Nutr Sci Vitaminol(Tokyo),2019,65(1):24-30.
[14] Savini S,Correani A,Pupillo D,et al. Phytosterol Esterification is Markedly Decreased in Preterm Infants Receiving Routine Parenteral Nutrition [J]. Lipids,2016,51(12):1353-1361.
[15] Correani A,Pignotti A,Marinelli L,et al. Plasma Phytosterol Half-Life and Levels Are Increased in Very Low Birth Weight Preterm Infants with Parenteral Nutrition-Associated Cholestasis [J]. Lipids,2018,53(7):717-725.
[16] Calder PC. Omega-3 fatty acids and inflammatory processes:from molecules to man [J]. Biochem Soc Trans,2017,45(5):1105-1115.
[17] Rangel SJ,Calkins CM,Cowles RA,et al. Parenteral nutrition-associated cholestasis:an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review [J]. J Pediatr Surg,2012,47(1):225-240.
[18] Anaya-Flórez MS,Barbosa-Cortés L,Villasis-Keever MA,et al. Two parenteral amino acid solutions and plasma levels of amino acids in the neonate:A randomized trial [J]. Nutrition,2019,65(31):202-207.
[19] Gupta K,Wang H. Parenteral Nutrition-Associated Cholestasis in Premature Infants:Role of Macronutrients [J]. JPEN J Parenter Enteral Nutr,2016,40(3):335-341.
[20] Gupta K,Wang H. Copper Supplementation in Premature Infants With Parenteral Nutrition-Associated Cholestasis [J]. Nutr Clin Pract,2018,33(5):718-724.
[21] Yang XF,Liu GS. Correlation between mutation of MDR3 gene exon 6 and parenteral nutrition-associated cholestasis of preterm infants [J]. Exp Ther Med,2014,8(5):1655-1659.
[22] Fujikura K,Yamasaki T,Otani K,et al. BSEP and MDR3:Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas [J]. Am J Surg Pathol,2016,40(5):689-696.
[23] 杨秀芳,柳国胜,陈玉兰,等.胃肠外营养相关性胆汁淤积症早产儿血MDR3基因mRNA表达[J].中国当代儿科杂志,2019,21(2):125-130.
[24] El Kasmi KC,Anderson AL,Devereaux MW,et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury [J]. Hepatology,2012,55(5):1518-1528.
[25] Suominen JS,Lampela H,Heikkil?覿 P,et al. APRi predicts native liver survival by reflecting portal fibrogenesis and hepatic neovascularization at the time of portoenterostomy in biliary atresia [J]. J Pediatr Surg,2015,50(9):1528-1531.
[26] Hwang JH. Predictive value of the aspartate aminotransferase to platelet ratio index for parenteral nutrition associated cholestasis in extremely low birth weight infants [J]. BMC Pediatr,2019,19(1):126.
[27] Cahová M,Daňkova H,Heczková M,et al. MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients [J]. Physiol Res,2019,68(4):681-688.
[28] 庞隐,张汝娟,杜晓娅.血清脂联素对极低出生体重早产儿胃肠外营养相关性胆汁淤积的相关性分析[J].中国儿童保健杂志,2016,24(9):951-954.
[29] Bae HJ,Shin SH,Kim EK,et al. Effects of cyclic parenteral nutrition on parenteral nutrition-associated cholestasis in newborns [J]. Asia Pac J Clin Nutr,2019,28(1):42-48.
[30] Park HW,Lee NM,Kim JH,et al. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates:a systematic review and meta-analysis [J]. J Nutr,2015,145(2):277-283.
[31] Costa S,Iannotta R,Maggio L,et al. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis [J]. Ital J Pediatr,2018,44(1):101.
[32] Repa A,Binder C,Thanhaeuser M,et al. A Mixed Lipid Emulsion for Prevention of Parenteral Nutrition Associated Cholestasis in Extremely Low Birth Weight Infants:A Randomized Clinical Trial [J]. J Pediatr,2018,194(85):87-93.
[33] 刘盼盼.含鱼油和以豆油为主脂肪乳静脉营养对早产儿肠外营养相关性肝病影响的Meta分析[D].长春:吉林大学,2018.
[34] Sancak S,Gursoy T,Tuten A,et al. A pioneering study:oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants [J]. J Matern Fetal Neonatal Med,2018,31(8):988-992.
[35] Zhang AM,Sun ZQ. Mosapride combined with probiotics on gastrointestinal function and growth in premature infants [J]. Exp Ther Med,2017,13(6):2675-2680. |
|
|
|